Radiopharmaceutical Synthesizer Market
Radiopharmaceutical Synthesizer Market Study by Cyclotron, Nuclear Reactors, and Radionuclide Generators for Hospitals, Pharmaceutical Companies, and Academic & Research Centers From 2024 to 2034
Analysis of Radiopharmaceutical Synthesizer Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Radiopharmaceutical Synthesizer Market Outlook (2024 to 2034)
Worldwide revenue from the radiopharmaceutical synthesizers market is estimated to stand at US$ 6.6 billion in 2024 and is slated to increase at a CAGR of 8% to reach US$ 14.29 billion by 2034.
In nuclear medicine, radiopharmaceuticals are made using equipment called radiopharmaceutical synthesizers. These synthesizers combine radionuclides with other chemical substances to create specialized radiopharmaceuticals. Following synthesis, the radiopharmaceuticals are applied to medical treatments and diagnostic procedures, such as targeted radiation therapy and PET scans.
The market for radiopharmaceutical synthesizers is expected to increase steadily, with a good outlook currently in place. The growing incidences of chronic illnesses, developments in radiopharmaceutical research, and the need for customized treatment are some factors propelling the market.
Radiation-dependent PET-CT scanners are becoming increasingly popular, which is fueling the market's expansion. Detailed functional and anatomical information is provided by PET-CT imaging, which helps with early illness identification and precise diagnosis.
The advent of fully automated systems and enhanced synthesis processes, among other technological developments in radiopharmaceutical synthesizers, are driving market expansion. These developments lead to faster and more effective synthesis, which lowers the cost and manufacturing time of radiopharmaceuticals overall.
The market is anticipated to grow further because pharmaceutical corporations and academic institutions investing more in research and development. By creating new and improving, the ones that already exist; these investments hope to increase the range of applications for radiopharmaceutical synthesizers.
In conclusion, it is projected that the market will expand significantly during the next several years. Growth in the market is fueled by elements, including the growing incidence of chronic illnesses, technological developments, and more spending on R&D.
| Report Attribute | Detail |
|---|---|
| Radiopharmaceutical Synthesizer Market Size (2024E) | US$ 6.6 Billion |
| Forecasted Market Value (2034F) | US$ 14.29 Billion |
| Global Market Growth Rate (2024 to 2034) | 8% CAGR |
| North America Market Value (2024E) | US$ 2.3 Billion |
| Mexico Market Value (2034F) | US$ 295.3 Million |
| Hospitals Segment Growth Rate (2024 to 2034) | 8% CAGR |
| Canada Market Value (2034F) | US$ 612 Million |
| Key Companies Profiled | IBA; Elysia; IAEA; Advison Inc.; Advanced Cycolotron Systems; JSC Isotope; Lantheus Medical Imaging; BV Cyclotron UV; LabLogic Systems Ltd; NorthStar Medical Technologies |
Radiopharmaceutical synthesizers make pharmaceutical products, which contain small amounts of radioisotopes by irradiating a specific target, which are found inside a nuclear research reactor or in a particle accelerator. Once these radioisotopes are produced, they are tagged on certain molecules based on biological capabilities, which results in radiopharmaceuticals.
As with any medical or pharmaceutical product, radiopharmaceuticals are required to be produced under carefully controlled conditions and are subject to stringent tests for their quality before they are made commercially available.
More than 100 radiopharmaceuticals have been developed, using radioisotopes, which were either produced through nuclear reactors or particle accelerators. Radiopharmaceuticals are used to diagnose various medical problems like cardiac anomalies or neurological conditions and are used to treat certain conditions, such as cancers.
In 2018, the United States FDA and nuclear regulatory authority took steps in order to ensure the supply of a critical radioisotope, which is used as an imaging tracer to detect life-threatening diseases. The FDA approved NorthStar Medical Radioisotopes’ RadioGenix system, which is a unique system used for producing molybdenum-99 (Mo-99), a medical radioisotope.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Radiopharmaceutical Synthesizer Market: Drivers and Restraints
Primary factors driving the radiopharmaceutical synthesizer market include the growing need for safe and effective guiding technology during the diagnosis and prognosis of various medical anomalies. Besides, the need for accurate procedures to diagnose cardiac neurological, and cancerous diseases the discovery of new radiopharmaceuticals has contributed to the growth in demand for radiopharmaceutical synthesizers across all end users.
Other than the increasing incidences of various anomalies, increasing awareness amongst the masses and an expanding application segment are driving the growth of the market. However, unawareness of the procedure in some developing countries is the factor limiting the growth of the global market, as opined in the radiopharmaceutical synthesizer industry outlook.
Radiopharmaceutical Synthesizer Market: Overview
The global market for radiopharmaceutical synthesizers is highly consolidated with several players operating in the global space. Combined approaches of using radiopharmaceutical synthesizers with several research and development companies to obtain accurate diagnosis and prognosis of conditions, such as cancer treatment is increasing over the period, which is expected to create high demand for radiopharmaceutical synthesizers in diagnostic applications.
Some of the well-established players in the market are IBA, Elysia, IAEA, Advion, Inc., Advanced Cyclotron Systems, and JSC Isotope, which are studied thoroughly in the radiopharmaceutical synthesizer industry analysis.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Radiopharmaceutical Synthesizer Market: Regional Wise Outlook
Geographically, the global radiopharmaceutical synthesizer market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the leader in the global market owing to the focus on key market players in the region.
The market in Asia Pacific excluding is expected to grow at significant CAGR due to expansion of product offerings by key players. Europe is expected to take a noteworthy share of the global market throughout the forecast period.
Radiopharmaceutical Synthesizer Market: Key Players
Examples of some of the major players in the global market are Mercurius Health, IBA, Elysia, IAEA, Advion, Inc., Advanced Cyclotron Systems, JSC Isotope, Lantheus Medical Imaging, Inc., BV Cyclotron VU, LabLogic Systems Ltd, NorthStar Medical Technologies Technological advancement in already marketed products is the major trend.
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The radiopharmaceutical synthesizer industry analysis also maps the qualitative impact of several market factors on segments and geographies.
The report covers an exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes
- North America (United States, Canada)
- Latin America (Mexico, Brazil)
- Europe (Germany, Italy, United Kingdom, Spain, France, Russia, Poland)
- Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segmentation of the Radiopharmaceutical Synthesizer Market Research
-
By Production Type :
- Cyclotron
- Nuclear Reactors
- Radionuclide Generators
-
By Indications :
- Cancer Treatment
- Neurology
- Cardiology
-
By End User :
- Hospitals
- Pharmaceutical Companies
- Academic and Research Centers
-
By Region :
- Northeast
- Southeast
- West
- Southwest
- Midwest
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Production Type
- 6.2. Indications
- 6.3. End User
- 7. Global Market Analysis and Forecast, By Production Type
- 7.1. Cyclotron
- 7.2. Nuclear Reactor
- 7.3. Radionuclide Generator
- 8. Global Market Analysis and Forecast, By Indications
- 8.1. Cancer Treatment
- 8.2. Neurology
- 8.3. Cardiology
- 9. Global Market Analysis and Forecast, By End User
- 9.1. Hospitals
- 9.2. Pharmaceutical Companies
- 9.3. Academic and Research Centers
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Production Type, Indications, and End User for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Mercurius Health
- 20.2. IBA
- 20.3. Elysia
- 20.4. IAEA
- 20.5. Advion Inc
- 20.6. Advanced Cyclotron Systems
- 20.7. JSC Isotope
- 20.8. Lantheus Medical Imaging Inc.
- 20.9. BV Cyclotron VU
- 20.10. LabLogic Systems Ltd
- 20.11. NorthStar Medical Technologies
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Production Type
Table 3: Global Market US$ Mn Forecast by Indications
Table 4: Global Market US$ Mn Forecast by End User
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Production Type
Table 7: North America Market US$ Mn Forecast by Indications
Table 8: North America Market US$ Mn Forecast by End User
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Production Type
Table 11: Latin America Market US$ Mn Forecast by Indications
Table 12: Latin America Market US$ Mn Forecast by End User
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Production Type
Table 15: Western Europe Market US$ Mn Forecast by Indications
Table 16: Western Europe Market US$ Mn Forecast by End User
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Production Type
Table 19: Eastern Europe Market US$ Mn Forecast by Indications
Table 20: Eastern Europe Market US$ Mn Forecast by End User
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Production Type
Table 23: East Asia Market US$ Mn Forecast by Indications
Table 24: East Asia Market US$ Mn Forecast by End User
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Production Type
Table 27: South Asia & Pacific Market US$ Mn Forecast by Indications
Table 28: South Asia & Pacific Market US$ Mn Forecast by End User
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Production Type
Table 31: MEA Market US$ Mn Forecast by Indications
Table 32: MEA Market US$ Mn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Production Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indications
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Why is the demand for radiopharmaceutical synthesizers increasing?
Growing requirement for safe and effective guiding technology for the diagnosis & prognosis of certain medical problems is increasing demand.
Which factor is adversely affecting the radiopharmaceutical synthesizer industry outlook?
Lack of information in developing economies brings down the sales of radiopharmaceutical synthesizers.
Which region is analyzed to remain dominant in the global radiopharmaceutical synthesizer market?
North America will remain the leading market for radiopharmaceutical synthesizers.
Radiopharmaceutical Synthesizer Market